Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000213127

Medchemexpress LLC Methyl 4-[8-(hydroxyamino)-8-oxooctanoyl]oxybenzoate | 946150-57-8 | MFCD28986227 | 98.0% | 323.34 | C16H21NO6 | 25 MG
SDP

Supplier:  Medchemexpress LLC HY10036525MG

Encompass_Preferred

Remetinostat is a hydroxamic acid-based histone deacetylase (HDAC) inhibitor supplied as a white to off-white solid for laboratory research. It has demonstrated efficacy in imiquimod-induced models of psoriatic dermatitis and is used in preclinical studies of cutaneous T-cell lymphoma. The compound is supplied with defined purity and storage recommendations to support reproducible experiments.

  • Hydroxamic acid-based histone deacetylase (HDAC) inhibitor.
  • Validated activity in psoriatic dermatitis animal models.
  • Applicable to studies of cutaneous T-cell lymphoma mechanisms.
  • High purity suitable for research (98.0%).
  • Stable solid form with recommended cold storage for prolonged shelf life.

Catalog No. 50-002-13127


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.